Both systemic lupus erythematosus and lupus nephritis reduce a person’s life expectancy, with SLE cutting an average of 12.4 years off a person’s life expectancy and lupus nephritis reducing life expectancy by another 2.7 years, according to a study by Mok et al. “Thus, the occurrence of renal damage is an important adverse factor for survival in patients with SLE,” they wrote. Treatment is aimed at reducing symptoms, preserving kidney function and avoiding the need for dialysis or kidney transplant, reducing morbidity and mortality, and minimizing medication-related toxicities. Review our collection of articles on the topic below. Features are added often, so check back frequently.
FEATURED ARTICLE: B Original: B Cells, Non-Invasive Biomarkers & More